Patent · US Active

Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors

US9017660B2 · kind B2 · utility

21Cited by

9References

61Claims

0Family size

Assignees

Advaxis, Inc. · US
The Trustees of the University of Pennsylvania · US

Inventors

Vafa Shahabi · Valley Forge, US
Anu Wallecha · Yardley, US
Paulo Maciag · Long Grove, US
Yvonne Paterson · Philadelphia, US
Nicola Mason · Philadelphia, US
Matthew Seavey · Secane, US

Key dates

Filing date	Aug 16, 2011
Grant date	Apr 28, 2015
Priority date	—
Expiry date	Oct 18, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/523
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides compositions and methods for treating and vaccinating against an Her2/neu antigen-expressing tumor and inducing an immune response against dominant in a non-human animal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.